Activity

Activity ID

15048

Expires

December 31, 2027

Format Type

Enduring

CME Credit

1.5

Fee

$0

CME Provider: Clinical Care Options, LLC

Description of CME Course

The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Major Depressive Disorder.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
Yes

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

Upon completion of this activity, participants should be able to:

Assess optimal timing and clinical rationale for switching or augmenting treatment in patients with MDD

Evaluate the pharmacologic profiles, efficacy, and safety of approved adjunctive therapies for adults with MDD that improve residual symptoms, including anhedonia and cognitive impairment

Apply current guideline- and evidence-based strategies to optimize dosing and titration of adjunctive therapies for adults with MDD who exhibit residual symptoms

Implement strategies for optimizing the management of persistent symptoms for complex or special populations with MDD to optimize long-term outcomes and functional recovery.

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

Practice Setting

Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.